Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05306340 |
|---|---|
| Brief Title: | A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) |
| First Submitted : | March 23, 2022 |
| First Submitted that Met QC Criteria : | March 23, 2022 |
| First Posted : | April 1, 2022 |
| Last Update Submitted that Met QC Criteria : | May 6, 2024 |
| Last Update Posted : | May 7, 2024 |